Factors associated with morbidity and mortality after gastric bypass. Alternatives for risk reduction: Sleeve gastrectomy;Factores asociados a morbimortalidad tras el bypass gástrico. Alternativas para disminuir riesgos: Gastroplastia tubular

Cirugia Espanola

Volumn 80, Issue 2, 2006, Pages 90-95

  Sánchez Santos, Raquel ^a   Ruiz de Gordejuela, Amador G ^a   Gómez, Nuria ^a   Pujol, Jordi ^a   Moreno, Pablo ^a   Francos, José Manuel ^a   Rafecas, Antonio ^a   Masdevall, Carlos ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Gastric bypass; Morbid obesity; Morbidity; Mortality; Prognostic factors; Sleeve gastrectomy

Indexed keywords

ADULT; ARTICLE; FEMALE; GASTRECTOMY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MORBIDITY; MORTALITY; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RISK FACTOR; RISK MANAGEMENT; STOMACH BYPASS;

ADULT; FEMALE; GASTRECTOMY; GASTRIC BYPASS; HUMANS; MALE; MIDDLE AGED; MORBIDITY; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS; RISK MANAGEMENT;

EID: 34447337778     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/S0009-739X(06)70929-0     Document Type: Article

References (27)

1. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. 894, 1-253. 200. Ref Type: Generic
2. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523-9.
3. Allison DB, Fontaine KR, Manson JE, Stevens J, Vanitallie TB. Annual deaths attributable to obesity in the United States. JAMA. 1999;282:1530-8.
4. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA. 2003;289:187-93.
5. Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean AP, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240:416-23.
6. Brolin RE. Complications of Roux-en-Y gastric bypass for morbid obesity. Curr Surg. 2003;60:138-42.
7. Byrne TK. Complications of surgery for obesity. Surg Clin North Am. 2001;81:1181-8.
8. Courcoulas A, Perry Y, Buenaventura P, Luketich J. Comparing the outcomes after laparoscopic versus open gastric bypass: a matched paired analysis. Obes Surg. 2003;13:341-6.
9. Bloomston M, Zervos EE, Camps MA, Goode SE, Rosemurgy AS. Outcome following bariatric surgery in super versus morbidly obese patients: does weight matter? Obes Surg. 1997;7:414-9.
10. Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med. 2005;352:1138-45.
11. Preston SH. Deadweight? The influence of obesity on longevity. N Engl J Med. 2005;352:1135-7.
12. Flum DR, Saleta L, Elrod JA, Dellinger EP, Cheadle A, Chan L. Early mortality among Medicare beneficiaries undergoing bariatric surgical procedures. JAMA. 2005;294:1903-8.
13. Mason EE, Doherty C, Maher JW, Scott DH, Rodriguez EM, Blommers TJ. Super obesity and gastric reduction procedures. Gastroenterol Clin North Am. 1987;16:495-502.
14. MacLean LD, Rhode BM, Forse RA. Late results of vertical banded gastroplasty for morbid and super obesity. Surgery. 1990;107:20-7.
15. Buchwald H. A bariatric surgery algorithm. Obes Surg. 2002;12:733-46.
16. Anthone GJ, Lord RV, DeMeester TR, Crookes PF. The duodenal switch operation for the treatment of morbid obesity. Ann Surg. 2003;238:618-27.
17. Gagner M, Matteotti R. Laparoscopic biliopancreatic diversion with duodenal switch. Surg Clin North Am. 2005;85:141-xi. Review.
18. Deveney CW, MacCabee D, Marlink K, Welker K, Davis J, McConnell DB. Roux-en-Y divided gastric bypass results in the same weight -loss as duodenal switch for morbid obesity. Am J Surg. 2004;187:655-9.
19. Livingston EH, Huerta S, Arthur D, Lee S, De Shields S, Heber D. Male gender is a predictor of morbidity and age a predictor of mortality for patients undergoing gastric bypass surgery. Ann Surg. 2002;236:576-82.
20. Regan JR Inabnet WB, Gagner M, Pomp A. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003;13: 861-4.
21. Nguyen NT, Longoria M, Gelfand DV, Sabio A, Wilson SE. Staged laparoscopic Roux-en-Y: a novel two-stage bariatric operation as an alternative in the super-obese with massively enlarged liver. Obes Surg. 2005;15:1077-81.
22. Mognol P, Chosidow D, Marmuse JP. Laparoscopic sleeve gastrectomy as an initial bariatric operation for high-risk patients: initial results in 10 patients. Obes Surg. 2005;15:1030-3.
23. Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI > or = 50). Obes Surg. 2005;15:612-7.
24. Lin E, Gletsu N, Fugate K, McClusky D, Gu LH, Zhu JL, et al, The effects of gastric surgery on systemic ghrelin levels in the morbidly obese. Arch Surg. 2004;139:780-4.
25. Geloneze B, Tambascia MA, Pilla VF, Geloneze SR, Repetto EM, Pareja JC. Ghrelin: a gut-brain hormone: effect of gastric bypass surgery. Obes Surg. 2003;13:17-22.
26. Langer FB, Reza Hoda MA, Bohdjalian A, Felberbauer FX, Zacherl J, Wenzl E, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15:1024-9.
27. Baltasar A, Serra C, Perez N, Bou R, Bengochea M, Ferri L. Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation. Obes Surg. 2005;15:1124-8.